Atlas Trials

Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Clinical trial NCT03162133 · COMPLETED

Trial details

NCT number
NCT03162133
Sponsor
Guangdong Provincial People's Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
Start date
2016-11-10
Primary completion
2017-11-10
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.